Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer.

PURPOSE The fundament hypothesis of conformal radiation therapy is that tumor control can be increased by using conformal treatment techniques that allow a higher tumor dose while maintaining an acceptable level of complications. To test this hypothesis, it is necessary first to estimate the incidence of morbidity for both standard and conformal fields. In this study, we examine factors that influence the incidence of acute grade 2 morbidity in patients treated with conformal and standard radiation treatment for prostate cancer. METHODS AND MATERIALS Two hundred and forty-seven consecutive patients treated with conformal technique are combined with and compared to 162 consecutive patients treated with standard techniques. The conformal technique includes special immobilization by a cast, careful identification of the target volume in three dimensions, localization of the inferior border of the prostate using the retrograde urethrogram, and individually shaped portals that conform to the Planning Target Volume (PTV). Univariate analysis compares differences in the incidence of RTOG-EORTC grade two acute morbidity by technique, T stage, age, irradiated volume, and dose. Multivariate logistic regression includes these same variables. RESULTS In nearly all categories, the conformal treatment group experienced significantly fewer acute grade 2 complications than the standard treatment group. Only volume (prostate +/- whole pelvis) and technique (conformal vs. standard) were significantly related to incidence of morbidity on multivariate analysis. When dose is treated as a continuous variable (rather than being dichotomized into two levels), a trend is observed on multivariate analysis, but it does not reach significant levels. The incidence of acute grade 2 morbidity in patients 65 years or older is significantly reduced by use of the conformal technique. CONCLUSION The conformal technique is associated with fewer grade 2 acute toxicities for all patients. This conclusion is valid irrespective of selection criteria except in a few cases. Older age is associated with increased toxicity only with the standard technique and not then at a statistically significant level. Elderly patients should not be excluded from external beam radiation because of increased morbidity especially if conformal treatment is available. Volume is not significantly related to morbidity in patients with standard treatment, but it is for conformal treatment. Furthermore, it remains significant in a multivariate analysis that also shows the advantage of conformal treatment. Grade 2 acute toxicities are more volume dependent than dose dependent.

[1]  G. Chen,et al.  Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. , 1993, International journal of radiation oncology, biology, physics.

[2]  G E Hanks,et al.  Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. , 1985, International journal of radiation oncology, biology, physics.

[3]  W. Sause,et al.  Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06. , 1987, International journal of radiation oncology, biology, physics.

[4]  S. Stokes,et al.  Treatment of stage I adenocarcinoma of the endometrium by hysterectomy and adjuvant irradiation: a retrospective analysis of 304 patients. , 1986, International journal of radiation oncology, biology, physics.

[5]  C. Perez,et al.  Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis. , 1980, International journal of radiation oncology, biology, physics.

[6]  Hanks Ge External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. , 1988 .

[7]  C. Perez,et al.  Tumor control in definitive irradiation of localized carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.

[8]  H. Sandler,et al.  Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  R. Mohan,et al.  Numerical scoring of treatment plans. , 1991, International journal of radiation oncology, biology, physics.

[10]  A S Lichter,et al.  Three-dimensional conformal radiation therapy: a testable hypothesis. , 1991, International journal of radiation oncology, biology, physics.

[11]  W. van Putten,et al.  Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. , 1990, International journal of radiation oncology, biology, physics.

[12]  G E Hanks,et al.  Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. , 1991, International journal of radiation oncology, biology, physics.

[13]  G E Hanks,et al.  The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.

[14]  J. Diamond,et al.  A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. , 1987, International journal of radiation oncology, biology, physics.